Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 68, Status: Authorised
Public webinar on shortages: putting patients first, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 4 November 2025, 14:00 (CET) to 4 November 2025, 16:00 (CET)
Agenda - Workshop on the use of Bayesian statistics in clinical development
ICH E21 Guideline on inclusion of pregnant and breastfeeding individuals in clinical trials
New guideline on inclusion of pregnant and breastfeeding individuals in clinical trials
Human medicines European public assessment report (EPAR): Ibrance, palbociclib, Date of authorisation: 09/11/2016, Revision: 24, Status: Authorised
Referral: Ixchiq, Chikungunya vaccine (live) Article 20 procedures Under evaluation, 03/06/2025
Patients and consumers
Human medicines European public assessment report (EPAR): Atropine sulfate FGK, atropine, Status: Opinion under re-examination
Referral: Mysimba, naltrexone,bupropion Article 20 procedures European Commission final decision, 27/03/2025, 22/05/2025, 03/06/2025